#Zymeworks
LightNews LightNews
bivnews.bsky.social
Vancouver biotech Zymeworks closes US$929M Theravance deal
Theravance deal diversifies Zymeworks’ portfolio beyond cancer-focused business
dlvr.it
September 24, 2026 at 11:13 PM
merlintrader.bsky.social
Zymeworks (#$ZYME): Theravance Shareholders Approve the Merger

Free Biotech Catalyst Calendar on Merlintrader.

www.merlintrader.com/zymeworks-st...
September 23, 2026 at 11:56 AM
secwatch.bsky.social
🚨 JUST IN: $TBPH
Theravance completes $17/share cash-plus-CVR merger with Zymeworks; delists from Nasdaq

#SEC #stocks #investing #TBPH #Mergers
🔗 secwatch.observer
Theravance completes $17/share cash-plus-CVR merger with Zymeworks; delists from Nasdaq
September 23, 2026 at 8:31 PM
reuters.com
Zymeworks strikes $929 million deal for Theravance Biopharma reut.rs/4ghgaD7
Zymeworks strikes $929 million deal for Theravance Biopharma
Zymeworks said on Monday it ​will buy Theravance Biopharma ‌in a $929 million all-cash deal, giving the drugmaker access ​to an approved ​treatment for a chronic lung ⁠condition.
reut.rs
June 29, 2026 at 10:50 AM
cellsandprots.bsky.social
Congrats to Dane Sands in our lab for his Zymeworks Fellowships Award in Advanced Protein Therapeutics
December 2, 2024 at 7:10 PM
cnbc.com
Stocks making the biggest moves premarket: Alphabet, Zymeworks, lithium producers, Quantum Computing, Clearwater Analytics and more
Stocks making the biggest moves premarket: Alphabet, Zymeworks, lithium producers, Quantum Computing, Clearwater Analytics and more
These are some of the stocks posting the largest moves in premarket trading.
cnb.cx
November 17, 2025 at 1:54 PM
seansilcoff.bsky.social
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
www.theglobeandmail.com/business/art...
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
Jazz Pharmaceuticals says the U.S. Food and Drug Administration has approved use of the tumor-fighting antibody to treat adults with a form of biliary-tract cancer (BTC)
www.theglobeandmail.com
November 21, 2024 at 8:45 PM
theglobeandmail.com
Zymeworks offers US$929-million for COPD drug maker Theravance
OMERS life sciences arm is providing US$350-million in additional financing for the deal
www.theglobeandmail.com
June 29, 2026 at 9:37 PM
quant-hub.bsky.social
🚨 $ZYME
On September 23, 2026, Zymeworks issued a press release announcing the closing of the Merger.
SEC Filing: ZYME
Click to view the official SEC document.
www.sec.gov
September 23, 2026 at 8:09 PM
codyshirriff.bsky.social
Vancouver is a biotech city that relied on on antibody companies like Abcellera and Zymeworks, but will be taken over by a new crop of companies, like Aspect Bio, Abdera, and who else?
January 19, 2024 at 4:40 AM
theglobeandmail.com
Zymeworks stock hits four-year high on promising results from digestive cancer trial
B.C. antibody drug developer continues multi-year comeback
www.theglobeandmail.com
November 18, 2025 at 1:47 AM
endpts.com
Zymeworks pays $929M for troubled biotech Theravance.
endpoints.news/zymeworks-to...
Zymeworks to acquire troubled biotech Theravance in $929M deal
Zymeworks to acquire Theravance Biopharma for $929M, gaining rights to COPD drug Yupelri's US profit share and ex-US royalties generating ~$60M annually.
endpoints.news
June 29, 2026 at 2:01 PM
stocktitan.net
#ZYME Zymeworks Announces Participation in Upcoming Investor Conferences

https://www.stocktitan.net/news/ZYME/zymeworks-announces-participation-in-upcoming-investor-y1odvg9aqlfs.html
November 21, 2024 at 11:05 AM
endpts.com
Zymeworks CEO makes the case for the $929M Theravance deal.
endpoints.news/zymeworks-ce...
Zymeworks CEO on why the Theravance deal is value for money
Zymeworks CEO Kenneth Galbraith makes the case for the $929M Theravance deal, arguing the net outlay is only about $120M.
endpoints.news
June 29, 2026 at 8:52 PM
stocktitan.net
#ZYME Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting

https://www.stocktitan.net/news/ZYME/zymeworks-announces-presentations-for-ziihera-zanidatamab-hrii-at-xk6khj9mw286.html
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse
www.stocktitan.net
March 18, 2026 at 11:46 AM
rscbmcs.bsky.social
📣 Register now for RSC-BMCS Hot Topics: Antibody-Drug Conjugates!
📅 Thursday 20 Nov 2025
📍 Virtual (Zoom)
Hear from Zymeworks, AZ, Genentech & Cambridge on ADC innovation.
🔗 Info: www.rscbmcs.org/events/hotto...
August 19, 2025 at 8:02 AM
bivnews.bsky.social
Vancouver biotech Zymeworks buying Theravance for US$929M
Transaction helps Zymeworks diversify and shift toward respiratory-disease treatments in addition to those for cancers
dlvr.it
June 29, 2026 at 7:32 PM
canadareport.org
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

Canada’s fastest news scan: 25+ headlines, no clutter, updated all day: CanadaReport.org

#cdnpoli #Canada #News #Business #Economy
Read Original Article 🔗
April 22, 2026 at 4:01 AM
fintwitter.bsky.social
ZYMEWORKS SHARES FALL 1.7% PREMARKET DAY AFTER CLIMBING TO FOUR-YEAR HIGH
November 18, 2025 at 10:16 AM
canadareport.org
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Cong...

Canada’s fastest news scan: 25+ headlines, no clutter, updated all day: CanadaReport.org

#cdnpoli #Canada #News #Business #Economy
Read Original Article 🔗
June 15, 2026 at 1:01 AM
markettwits.bsky.social
#JAZZ = +22% #ZYME = +35%

Jazz Pharmaceuticals and Zymeworks Report Positive Cancer Treatment Results
November 17, 2025 at 1:35 PM
secwatch.bsky.social
🚨 JUST IN: $TBPH
Theravance Biopharma to be acquired by Zymeworks for $17.00/share cash plus CVR

#SEC #stocks #investing #TBPH #Mergers
🔗 secwatch.observer
Theravance Biopharma to be acquired by Zymeworks for $17.00/share cash plus CVR
June 29, 2026 at 11:08 AM
glenkorstrom.bsky.social
Looked into Vancouver biotechnology company Zymeworks' success and how that may translate into good things for the city's life sciences scene.

#biotech #lifesciences #innovation
Could Zymeworks' blockbuster drug success revive Vancouver biotech scene?
B.C. venture has cancer drug set for commercialization, others in the pipeline
www.biv.com
December 12, 2025 at 1:40 AM
gwendolynawu.bsky.social
in a switch-up for Zymeworks, the cancer drugmaker is pursuing a royalty-based model after a data readout that suggests its medicines could be future blockbusters: www.biopharmadive.com/news/zymewor...
Zymeworks to change course, pursue ‘royalty-driven’ biotech model
On the heels of a data readout suggesting one of its cancer drugs could become a future blockbuster, Zymeworks is adopting a new strategy its CEO says will create “more consistent value for shareholde...
www.biopharmadive.com
November 19, 2025 at 9:03 PM
eresc79.bsky.social
I am extremely happy and excited to see that a drug that we developed at Zymeworks was just approved by the FDA.

#biparatopic #bispecific #antibody #Oncology #Immunotherapy #BiparatopicAntibodies #HER2 #InnovationInScience

www.fda.gov/drugs/resour...
FDA grants accelerated approval to zanidatamab-hrii
On November 20, 2024, the FDA granted accelerated approval to zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals, Inc.) for biliary tract cancer.
www.fda.gov
November 22, 2024 at 9:36 PM